Trial Profile
A study of pioglitazone for evaluation of bladder cancer risk in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2015
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 13 Oct 2015 New trial record
- 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.